1. Home
  2. Live Updates
  3. Enal cell carcinoma

Live Breaking News & Updates on Enal cell carcinoma

Stay informed with the latest breaking news from Enal cell carcinoma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Enal cell carcinoma and stay connected to the pulse of your community

Immunotherapy for Renal-Cell Carcinoma Saves Lives

A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.

United-kingdom , Boston , Massachusetts , United-states , Dana-farber-cancer-institute , Tonik-choueiri , European-medicines-agency , Harvard-medical-school , New-england-journal , Merck-sharp , Malignant-kidney-neoplasm-renal-cell-cancer-rcc-carcinoma-of-the

Groups Ask WHO to Recognize Chronic Kidney Disease Threat

Three international nephrology organizations call for World Health Organization recognition of CKD as a major noncommunicable mortality driver.

United-states , American , Anna-francis , Sustainable-development-goal , World-health-organization , International-society-of-nephrology , European-renal-association , American-society-of-nephrology , United-nations , International-society , American-society , Nature-reviews

Test Your Knowledge on Kidney Cancer

Kidney cancer is a disease in which the cells of the kidney become malignant, forming a tumor. Take this quiz to know more about kidney cancer.

Kidney-cancer , Enal-cancer , Enal-cell-carcinoma , Ilms-tumor , Idney-cancer-treatment , Ephrectomy ,

8 early signs of kidney cancer and symptoms you cannot ignore

Certain risk factors such as smoking, obesity, and high blood pressure can lead to kidney cancer. Genetics may also play a role in predisposing individuals to k

Chiplun , Maharashtra , India , Dattatraya-andure , Onco-life-cancer-centre , Consultant-medical-oncologist , Whatsapp-channels , Idney-cancer , Enal-cell-carcinoma , Idney-tumor , Idney-cancer-symptoms , Idney-cancer-treatment

New AI-powered protein mapping tool optimizes cancer therapy

Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumour, enabling clinicians to decide how to target treatment in a more precise way.

Eamonn-oneill , Head-of-bath-department-computer-science , Stanford-university-school-of-medicine-united-states , Research-council , Dr-amanda-kirane-laboratory , Centre-for-therapeutic-innovation , University-of-bath , University-of-bath-alumni-fund , Centre-for-doctoral-training-in-accountable , Hypoxia-induced-factor-alpha , Therapeutic-innovation , Stanford-university-school

AI tool maps protein function in tumors, paving way for personalized cancer treatment

Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumor, enabling clinicians to decide how to target treatment in a more precise way.

Eamonn-oneill , Head-of-bath-department-computer-science , Centre-for-therapeutic-innovation , Centre-for-doctoral-training-in-accountable , Dr-amanda-kirane-laboratory , University-of-bath , Stanford-university-school-of-medicine-united-states , Hypoxia-induced-factor-alpha , Therapeutic-innovation , Stanford-university-school , United-states , Doctoral-training

Immune-Related AEs Predict Outcomes in Advanced GU Cancers

Patients with advanced GU cancers who had immune-related AEs from immunotherapy had better overall survival — a phenomenon also reported for other cancer types.

Calgary , Alberta , Canada , Sichuan , Gansu , China , Chengdu , United-states , American , Vishal-navani , Yaowen-zhang , University-of-calgary

AVEO Oncology Announces Publication of Long-Term Survival

AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib...

Boston , Massachusetts , United-states , American , Junil-kim-junam , Michael-bailey , Kathryne-beckermann , Tranj-ornstein , Pharmaceuticals-inc , Drug-administration , Lg-chem-life-sciences-united-states-inc , Pharma-united-kingdom

'Breakthrough': Adjuvant Pembro Ups Survival in Renal Cancer

KEYNOTE-564 is the first trial to demonstrate an overall survival benefit with adjuvant immunotherapy in patients with clear cell renal cell carcinoma.

United-states , Massachusetts , Cleveland , Ohio , Dana-farber-cancer-institute , Boston , American , Pedroc-barata , Tonik-choueiri , Kidney-cancer-program-at-dana-farber-institute , American-society-of-clinical-oncology-genitourinary-symposium

Merck (MRK) Q4 2023 Earnings Call Transcript

MRK earnings call for the period ending December 31, 2023.

United-states , China , Argentina , Argentine , Chinese , American , Seamus-fernandez , Carter-gould-barclays , Geoff-meacham , Chris-schott-jpmorgan , Daina-graybosch-leerink , Peter-dannenbaum